These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12369742)

  • 21. Effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury.
    Topsakal C; Kilic N; Ozveren F; Akdemir I; Kaplan M; Tiftikci M; Gursu F
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1643-52. PubMed ID: 12897486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of alpha-lipoic acid on lipid peroxidation and antioxidant defence system in blood of insulin-resistant rats.
    Thirunavukkarasu V; Anuradha CV
    Diabetes Obes Metab; 2004 May; 6(3):200-7. PubMed ID: 15056128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
    Oliveira AC; Bertollo CM; Rocha LT; Nascimento EB; Costa KA; Coelho MM
    Eur J Pharmacol; 2007 Apr; 561(1-3):194-201. PubMed ID: 17343847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fenofibrate reduces tumor necrosis factor-alpha serum concentration and adipocyte secretion of hypercholesterolemic rabbits.
    Zhao SP; Wu J
    Clin Chim Acta; 2004 Sep; 347(1-2):145-50. PubMed ID: 15313152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related decrease in expression of peroxisome proliferator-activated receptor alpha and its effects on development of dyslipidemia.
    Ye P; Wang ZJ; Zhang XJ; Zhao YL
    Chin Med J (Engl); 2005 Jul; 118(13):1093-8. PubMed ID: 16098262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
    Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
    J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
    Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DRF 2655: a unique molecule that reduces body weight and ameliorates metabolic abnormalities.
    Vikramadithyan RK; Hiriyan J; Suresh J; Gershome C; Babu RK; Misra P; Rajagopalan R; Chakrabarti R
    Obes Res; 2003 Feb; 11(2):292-303. PubMed ID: 12582227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Agonist-induced down-regulation of hepatic glucocorticoid receptor via peroxisome proliferator-activated receptor in SD rats].
    Chen X; Li M; Sun WP; Bi Y; Cai MY; Liang H; Yu QQ; He XY; Weng JP
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3276-9. PubMed ID: 20193367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet.
    Choi MS; Lee MK; Jung UJ; Kim HJ; Do GM; Park YB; Jeon SM
    Mol Nutr Food Res; 2009 Jun; 53(6):751-9. PubMed ID: 19205001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
    J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
    Zhao X; Li LY
    Am J Nephrol; 2008; 28(4):598-606. PubMed ID: 18277067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity.
    Hou X; Shen YH; Li C; Wang F; Zhang C; Bu P; Zhang Y
    Biochem Biophys Res Commun; 2010 Apr; 394(3):653-9. PubMed ID: 20226762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits.
    Zhao SP; Li J; Xu Z; Wu J; Li Q; Ye H
    Clin Chim Acta; 2004 Nov; 349(1-2):81-6. PubMed ID: 15469859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol.
    Kooistra T; Verschuren L; de Vries-van der Weij J; Koenig W; Toet K; Princen HM; Kleemann R
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2322-30. PubMed ID: 16873727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
    Grabacka M; Plonka PM; Urbanska K; Reiss K
    Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease].
    Márk L; Márki-Zay J; Orosz I; Kondacs A; Erdei F; Katona A
    Orv Hetil; 2003 Apr; 144(16):765-8. PubMed ID: 12778627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of peroxisome proliferator-activated receptor-alpha agonist on adipokines expression in rats fed with high-fat diet].
    Li Y; Huang B; Cheng H; Liang Z; Liu SY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):761-5. PubMed ID: 17260462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
    Roglans N; Bellido A; Rodríguez C; Cabrero A; Novell F; Ros E; Zambón D; Laguna JC
    Clin Pharmacol Ther; 2002 Dec; 72(6):692-701. PubMed ID: 12496750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.